doi: 10.1186/s10020-020-00179-x 122 KocFTekeliMYKanburMKarayigitMLimanBC
It can allow for more gradual escalation of doses when starting treatment and reduce the GI side effects that most commonly occur during this period, says Kushner
Key takeaway: Retatrutide delivers 24.2% weight loss (versus 14.9% for Wegovy and 20.9% for Zepbound) while maintaining a side effect profile thats actually better than Wegovy in several categories
How It Works: Gradually elevates the collapsed nostril to improve its position
2-
Population-scale studies of incretin response, glucagon receptor sensitivity, central appetite-control variants, lipid handling pathways, energy-expenditure-related loci, muscle-preservation genetics, and the cardiovascular-protection signaling that may explain real-world MACE differences, these literatures exist, they are growing, and they are starting to converge on a set of variants whose effect sizes are large enough to influence the prior distribution from which a clinician chooses a starting molecule